Spiroxatrine
Spiroxatrine is a drug which acts as a selective antagonist at both the 5-HT1A receptor and the α2C adrenergic receptor.[1] It is an analog of spiperone and also has some dopamine antagonist effects.
Names | |
---|---|
IUPAC name
8-(2,3-Dihydro-1,4-benzodioxin-2-ylmethyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one | |
Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
ChEMBL | |
ChemSpider |
|
MeSH | Spiroxatrine |
PubChem CID |
|
UNII | |
CompTox Dashboard (EPA) |
|
InChI
| |
SMILES
| |
Properties | |
Chemical formula |
C22H25N3O3 |
Molar mass | 379.460 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
Infobox references |
Synthesis
Note well that the piperidine intermediate has a venerable history & has been incorporated into in the synthesis of the following drugs: Spiperone, Fluspirilene, Ro65-6570, RP-23618, Spirilene, Spiramide, R 5260 [1109-69-9], PCP-Antipsychotic mixture. Although it looks like most agents are antipsychotics, more applications might be possible. Indeed, manipulations to the molecular structure meant some of the agents behave as opioids.
Convergent synthesis between 2-Bromomethyl-1,4-benzodioxane [2164-34-3] (1) and 1-Phenyl-1,3,8-triazaspiro[4.5]decan-4-one [1021-25-6] (2) completes the synthesis of Spiroxatrine (3)
References
- Terrón, J. A.; Ibarra, M; Ransanz, V; Hong, E; Villalón, C. M. (1993). "The alpha-antiadrenergic properties of spiroxatrine, a ligand of serotonergic 5-HT1A receptors". Archivos del Instituto de Cardiología de México. 63 (4): 289–95. PMID 8105762.
- Janssen Paul Adriaan Jan, U.S. Patent 3,238,216 (1966 to Res Lab Dr C Janssen N V).